Bliss GVS Pharma informs about unaudited financial results

01 Dec 2017 Evaluate

Bliss GVS Pharma has informed that the Board Meeting of the Company was held on November 30, 2017 at the registered office of the Company at 04.00 p.m. The Board considered and approved the Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2017; and Limited Review Report on Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

171.05 4.35 (2.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×